Revolutionizing Women’s Healthcare: Samphire Neuroscience Secures CVX Ventures Funding

Samphire staff

CVX Ventures is proud to announce the successful closure of an investment round for Samphire Neuroscience, a groundbreaking UK medtech startup dedicated to transforming women’s health through innovative technology. Samphire is dedicated to managing period pain and mood disorders with its state-of-the-art, brain-stimulating wearable device, Nettle.

Bridging the Gap in Women’s Health

Samphire Neuroscience addresses the often overlooked and enduring issue of menstrual pain and associated mood disorders, offering a drug-free, non-invasive solution. The Nettle headband, through direct current stimulation, targets brain regions related to pain perception and mood regulation. This revolutionary approach aims to alleviate the physical and emotional symptoms of menstrual cycles, representing a significant leap forward in women’s health.

With promising clinical trials showcasing a 52% reduction in pain and improved mood symptoms, Nettle is positioned to offer a significant improvement in quality of life for many women.

A Milestone Investment for a Brighter Future

The recent $2.3 million pre-seed funding round, supported by CVX Ventures and other investors, marks a pivotal moment for Samphire Neuroscience. We are proud of our commitment to supporting innovative solutions that address critical gaps in healthcare, particularly in areas as underrepresented as women’s health.

Our partnership with Samphire not only highlights the potential of Nettle to revolutionize the management of menstrual pain and mood disorders but also emphasizes our belief in the importance of investing in women’s health technology. This sector, historically neglected, stands to benefit significantly from such focused attention and innovation.

We are excited about the potential impact this device will have on the lives of millions of women across Europe and, eventually, the globe. 

At CVX Ventures, we remain dedicated to identifying and nurturing startups that push the boundaries of technology and healthcare. Samphire Neuroscience represents just one of the many ways we aim to contribute to a healthier future for all.

Are you a startup looking for funding and support to bring your innovative ideas to life? Reach out to our Investment Manager, Sara Nahon, at to explore how we can help you achieve your goals.

Read more about Samphire at TechCrunch here: 

Press enquiries

Kim Jessica Axholt, CMO

Mikkel Fruergaard, CEO

Find ud af, om CVX er et match for din virksomhed

Du skal blot udfylde nedenstående felter, og så tager vi kontakt hurtigst muligt ift. den kommende proces.

Picture of Har du spørgsmål?

Har du spørgsmål?

Så er du velkommen til at kontakte Investment Manager, Sara Nahon, på

Få et møde

Hvis du har spørgsmål til, hvordan vi investerer eller hjælper med bestyrelsesposter, så kan du booke et møde herunder: 

Picture of Spørgsmål omkring bestyrelse?

Spørgsmål omkring bestyrelse?

Oscar Thybo, Senior Manager of Board & Advisory

Få et møde →
Picture of Spørgsmål omkring partnere?

Spørgsmål omkring partnere?

Joakim Herrestrup, Head of Partner Relations

Få et møde →

Discover if CVX is a match for your startup business

Simply fill out the fields below and we’ll get back to you as soon as possible. the upcoming process.

Picture of Do you have any questions?

Do you have any questions?

Please contact Investment Manager, Sara Nahon, at

Get a meeting

If you have questions about how we invest or help with board positions, you can book a meeting below:

Picture of Questions about the board?

Questions about the board?

Katrine Gilberg , Head of Board & Advisory

Get a meeting →
Picture of Questions about partners?

Questions about partners?

Joakim Herrestrup, Head of Partner Relations

Get a meeting →